PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31846070-5	2020	Extensive in vitro and preclinical research has demonstrated that niclosamide was found to exert potent anticancer and anti-inflammatory properties by targeting STAT3, p65 NF-kappaB, and NFATc-1 signaling paradigm with minimal host toxicity.	Niclosamide	66-77	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	168-171	
31846070-10	2020	Additionally, our results provided a preclinical rationale in imiquimod (IMQ)-induced BALB/c mouse model, where niclosamide diligently mitigated the IMQ-induced epidermal hyperplasia and inflammation by downregulating STAT3, p65 NF-kappaB, and NFATc-1 transcription factors along with Akt, Ki-67, and ICAM-1 protein expression.	Niclosamide	112-123	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	225-228	
27492973-0	2017	Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/beta-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.	Niclosamide	13-24	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	51-54	
27492973-12	2017	CONCLUSIONS: Interaction of p65 with FOXM1/beta-catenin is critical in CML and its disruption by niclosamide eradicates LSCs.	Niclosamide	97-108	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	28-31	
27535961-5	2016	When the recipient mice were treated with niclosamide for 3 weeks, niclosamide reduced the size of endometriotic implants with inhibition of cell proliferation, and inflammatory signaling including RELA (NFKB) and STAT3 activation, but did not alter expression of steroid hormone receptors.	Niclosamide	42-53	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	198-202	
27535961-5	2016	When the recipient mice were treated with niclosamide for 3 weeks, niclosamide reduced the size of endometriotic implants with inhibition of cell proliferation, and inflammatory signaling including RELA (NFKB) and STAT3 activation, but did not alter expression of steroid hormone receptors.	Niclosamide	67-78	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	198-202